Logo

NICE

NICE Ltd.

NICE

NICE Ltd. • NASDAQ
$106.07 ▲ 0.80% (+0.84)
Market Cap $6.58 B
52w High $193.52
52w Low $99.00
Dividend Yield 0%
P/E 12.05
Volume 459.13K
Outstanding Shares 62.03M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $731.999M ▲ $328.295M ▲ $144.853M ▼ 19.789% ▼ $2.33 ▼ $218.363M ▲
Q2-2025 $726.712M ▲ $324.519M ▲ $187.404M ▲ 25.788% ▲ $3.01 ▲ $205.204M ▲
Q1-2025 $700.192M ▼ $319.943M ▼ $129.29M ▲ 18.465% ▲ $2.04 ▲ $191.61M ▼
Q4-2024 $721.6M ▲ $334.902M ▲ $99.509M ▼ 13.79% ▼ $1.56 ▼ $200.472M ▲
Q3-2024 $689.963M $318.898M $120.921M 17.526% $1.91 $195.16M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $455.892M ▼ $5.152B ▼ $1.291B ▼ $3.861B ▲
Q2-2025 $1.632B ▲ $5.31B ▲ $1.578B ▼ $3.731B ▲
Q1-2025 $1.611B ▼ $5.232B ▼ $1.732B ▲ $3.5B ▼
Q4-2024 $1.622B ▲ $5.296B ▲ $1.693B ▲ $3.59B ▲
Q3-2024 $1.527B $5.189B $1.608B $3.568B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $144.853M ▼ $190.5M ▲ $195.725M ▲ $-500.536M ▼ $-116.398M ▼ $183.242M ▲
Q2-2025 $187.404M ▲ $61.322M ▼ $29.013M ▲ $-30.506M ▲ $64.968M ▲ $38.606M ▼
Q1-2025 $129.29M ▲ $285.071M ▲ $-47.995M ▲ $-251.654M ▼ $-13.431M ▲ $264.638M ▲
Q4-2024 $99.509M ▼ $249.522M ▲ $-330.431M ▼ $-94.788M ▼ $-183.871M ▼ $225.136M ▲
Q3-2024 $120.921M $158.961M $-149.832M $-86.409M $-72.772M $131.73M

Five-Year Company Overview

Income Statement

Income Statement NICE shows a clear pattern of healthy growth and steadily improving profitability over the past several years. Revenue has climbed each year, and profits have grown faster than sales, which suggests the business is scaling efficiently. Gross margins are high for a software company and have gradually strengthened, indicating solid pricing power and good control of delivery costs. Operating and net income have moved up consistently, showing that the company is managing expenses while still investing for growth. Overall, the income statement paints a picture of a mature, profitable software vendor that is still growing at a meaningful pace, with improving efficiency rather than simply expanding at any cost.

Balance Sheet

Balance Sheet The balance sheet looks solid and generally conservative. Total assets and shareholder equity have grown over time, which signals that the company is building its asset base and retaining value rather than relying heavily on borrowing. Debt is present but appears manageable relative to equity, and it has not ballooned in recent years. Cash levels have stayed fairly steady, providing a reasonable liquidity cushion without the appearance of excess idle funds. In simple terms, NICE seems to be financing growth primarily through its own success, with a balanced use of debt and a strong equity foundation.

Cash Flow

Cash Flow NICE’s cash flow profile is a strong point. Cash generated from day‑to‑day operations has increased steadily and now comfortably covers its modest investment needs. Free cash flow has trended upward alongside earnings, which shows that reported profits are being backed by real cash, not just accounting entries. Capital spending remains relatively light, typical for a software business, so a large share of operating cash can be directed toward R&D, cloud infrastructure partnerships, or strategic initiatives. This healthy cash engine reduces reliance on external financing and gives the company flexibility to navigate industry shifts.

Competitive Edge

Competitive Edge NICE occupies a strong niche in customer experience and contact center software, especially in cloud and AI‑driven solutions. Its CXone platform is a central asset, providing an integrated suite that can be hard for customers to replace once embedded in their operations. The company’s profitability metrics stand well above many peers, hinting at a meaningful competitive moat built from technology depth, scale, and long‑term customer relationships. At the same time, it operates in a fiercely competitive arena with large players like Salesforce and other specialized vendors. The main competitive risks come from rapid innovation cycles in AI, aggressive pricing or bundling by bigger platforms, and the constant pressure to prove that NICE’s specialized tools deliver better outcomes than more generic alternatives.

Innovation and R&D

Innovation and R&D Innovation is clearly at the core of NICE’s strategy. It spends a significant portion of its revenue on research and development, at a level that signals a long‑term commitment rather than short‑term optimization. The company has leaned into an “AI‑first” approach, with CXone and newer offerings like Mpower tools aiming to automate and orchestrate customer interactions from end to end. Its emphasis on tailored, domain‑specific AI — rather than generic models — is a key differentiator and helps address concerns around accuracy, privacy, and reliability. Partnerships, such as the alliance with a major consulting firm, should amplify the reach of its technology. The main risk is execution: sustaining this pace of innovation while integrating new AI capabilities smoothly into customer workflows is complex, and competitors are racing in the same direction.

Summary

Bringing it all together, NICE looks like a well‑established, profitable software company that has successfully shifted its center of gravity toward cloud and AI‑driven customer experience solutions. The financial statements show steady growth, expanding margins, a strong equity base, and robust free cash flow — all signs of a disciplined operator rather than a speculative story. Its competitive position is underpinned by a broad, integrated platform and strong domain expertise, which may create switching costs and support above‑average profitability. However, the company operates in a fast‑moving and crowded field, where large technology platforms and emerging AI players are constantly challenging incumbents. Future performance will likely hinge on how well NICE continues to innovate in AI, deepen its cloud footprint, and prove to customers that its specialized, orchestrated solutions deliver more value than generic or in‑house alternatives.

NEWS

November 28, 2025 · 8:30 AM UTC

NiCE Announces Upcoming Conference Participation

Read more

November 25, 2025 · 9:18 AM UTC

OneMeta Inc. Appoints Former NICE CXone, Telefonica, and U.S. Bank Technology Leaders as Strategic Advisors

Read more

November 25, 2025 · 4:00 AM UTC

NICE Recommends AUCATZYL® (obecabtagene autoleucel) as a Treatment Option for Adult Patients (≥26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹

Read more

November 24, 2025 · 8:10 AM UTC

Nanox.AI Bone Solutions, Advanced AI-Powered Software for Spine Assessment, Recommended by NICE for Early Value Assessment in UK National Health Service hospitals

Read more

November 19, 2025 · 8:00 AM UTC

NiCE Named a Leader in IDC MarketScape European Contact Center-as-a-Service Vendor Assessment 2025

Read more